We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Outlook Therapeutics
OTLK
$266M
| $35.1K | ﹤0.01% |
1,009
+99
| +11% | +$2.7K |
|
1802
Energy Vault
NRGV
$522M
| $34.8K | ﹤0.01% |
+12,753
| New | +$26.9K |
|
|
FRGE
1803
DELISTED
Forge Global Holdings
FRGE
| $34.7K | ﹤0.01% |
+953
| New | +$23.4K |
|
1804
SelectQuote
SLQT
$113M
| $34.6K | ﹤0.01% |
17,746
+1,812
| +11% | +$3.05K |
|
|
PTRA
1805
DELISTED
Proterra Inc. Common Stock
PTRA
| $34.6K | ﹤0.01% |
28,806
+2,489
| +9% | +$3.06K |
|
|
KZR
1806
DELISTED
Kezar Life Sciences
KZR
| $34.2K | ﹤0.01% |
1,397
+303
| +28% | +$7.89K |
|
1807
BlackSky Technology
BKSY
$803M
| $34.1K | ﹤0.01% |
+1,922
| New | +$23K |
|
1808
Nuvation Bio
NUVB
$2.26B
| $34.1K | ﹤0.01% |
18,946
+5,246
| +38% | +$8.92K |
|
|
GRTS
1809
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $33.5K | ﹤0.01% |
+17,168
| New | +$40.2K |
|
1810
Hyliion Holdings
HYLN
$665M
| $32.1K | ﹤0.01% |
19,200
+3,033
| +19% | +$5.11K |
|
1811
Ribbon Communications
RBBN
$354M
| $31.9K | ﹤0.01% |
+11,425
| New | +$31.7K |
|
1812
X4 Pharmaceuticals
XFOR
$365M
| $31.1K | ﹤0.01% |
+534
| New | +$27.4K |
|
1813
Atara Biotherapeutics
ATRA
$71.6M
| $30.2K | ﹤0.01% |
751
+41
| +6% | +$2.32K |
|
|
AMRN
1814
Amarin Corp
AMRN
$284M
| $29.6K | ﹤0.01% |
1,244
-80
| -6% | -$2.05K |
|
|
AMRS
1815
DELISTED
Amyris Inc.
AMRS
| $29.4K | ﹤0.01% |
28,578
+4,631
| +19% | +$4.31K |
|
|
BHIL
1816
DELISTED
Benson Hill, Inc.
BHIL
| $29.3K | ﹤0.01% |
644
+68
| +12% | +$2.91K |
|
1817
Rigel Pharmaceuticals
RIGL
$681M
| $28.7K | ﹤0.01% |
2,226
+195
| +10% | +$2.64K |
|
|
NGM
1818
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $28.5K | ﹤0.01% |
10,997
+550
| +5% | +$1.96K |
|
1819
Cartesian Therapeutics
RNAC
$232M
| $28K | ﹤0.01% |
834
+480
| +136% | +$17.2K |
|
1820
Rackspace Technology
RXT
$1B
| $27.9K | ﹤0.01% |
+10,252
| New | +$16.9K |
|
|
DNMR
1821
DELISTED
Danimer Scientific, Inc.
DNMR
| $27.2K | ﹤0.01% |
285
+18
| +7% | +$2.31K |
|
1822
Ring Energy
REI
$320M
| $26.7K | ﹤0.01% |
15,599
+4,503
| +41% | +$8.25K |
|
1823
Advantage Solutions
ADV
$485M
| $26.4K | ﹤0.01% |
+452
| New | +$19.3K |
|
|
TRUE
1824
DELISTED
TrueCar
TRUE
| $25.9K | ﹤0.01% |
11,471
+1,187
| +12% | +$2.83K |
|
|
PSTX
1825
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $25.4K | ﹤0.01% |
+14,454
| New | +$36.9K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.